Healthtech Summit selects Medopad as a Top 20 Digital Health Company in Europe
Medopad has been selected as a top 20 Digital Health company in Europe at the Healthtech Summit - Tech Tour. This is the second year running Medopad has received this accolade.
Medopad was selected from hundreds of applicants and nominations to present to a group of prestigious international investors, venture capitalists, corporate partners and business angels at the SwissTech Convention Centre and Biopôle in Lausanne, Switzerland.
Pierre Chauvineau, Vice President of Boston Scientific and President of Healthtech Summit mentioned: “This year’s Summit is happening at a time when many insiders are commenting that digital health is at an ‘inflection point’. Healthcare is finally embracing digital health solutions in the mainstream and it is likely that the winners and losers of tomorrow will be decided around these concepts.”
A dedicated committee of leading international investors, senior business leaders and healthcare representatives conducted a rigorous review process to identify the 20 companies. Companies were judged on the uniqueness of their technology, the strength of their business model, vision, capability to execute on their business plan, and the quality and track record of their management.
Read about our latest news and achievements.
NSPCC using Medopad to enhance child support servicesRead More
Medopad, the UK-based health-tech AI company, has today announced it has secured US$28m in funding at the first close of its Series A fund raise round. The target is to raise US$120m over the coming months in equity capital.Read More
and many more...